STUDY OF THE STATE OF TISSUE REMODELING IN PERSONS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISPLASI
Keywords:
undifferentiated connective tissue dysplasia, matrix metalloproteinase’s, inhibitors of matrix metalloproteinase’s, magnesium (Mg2 ) ionsAbstract
Objective: to carry out comparative analysis of matrix metalloproteinase’s-2,9 (MMP-2, 9), tissue inhibitors of matrix metalloproteinase’s (TIMP) expression indexes and their interconnection with magnesium ions (Mg2+), glucosamine-glycans and glucuronidases activity in the blood of patients with undifferentiated connective tissue dysplasia. Material and research methods. 208 persons of them aged 15-25 (19.9±1.42) years have been studied. Depending on clinical signs and progressive complications, patients were divided into 2 groups, 1-group 97 patients with signs of external phenotypes (fens) of BTDD, 2-group 111 patients with signs of external and internal fens, with some complications. Results of researches have shown that the blood of patients with BTDD showed an increase in MMP-2 and MMP-9 and a decrease in TIMP-1. As the progression of the disease increases, the expression of MMP-2 and MMP-9 increases and the TIMP-1 decreases, compared to the data in the control group. At the same time, in patients there is a decrease in Mg 2 ions in blood. Thus, dynamics of changes of MMP-2 and MMP-9 and also TIMP-1 expression in patients with undifferentiated connective tissue dysplasia may serve as a method of estimation of progressive pathological process and prognosis of the disease.
References
Altura B.M. Basic biochemistry and physiology of magnesiym; A brief reviem // Magnesium and Frace Elements.- 2011.- Vol.10.- P.167–171.
Babamuradova Z.B. Значение фенотипических, генетических маркеров на развитие, течение и раннюю диагностику недифференцированной дисплазии соединительной ткани // PhD dissertatsiya. – 2020. – 15-20 bet.
Babamuradova Z.B., Shodikulova G.Z., Mirzaev O.V. Treatment of patients with undifferentiated connective tissue dysplasia in mitral valve prolapse with varying degrees of mitral regurgitacion // European Science Review – Vena, 2018. – Volume 3-4, March-April. – Р.140-143
Bobkowski W., Nowak A., Durlach J. The importance of magnesium status in the pathophysiology of mitral valve prolapsed //Magnes. Res.- 2005.- Vol.18 (1).- P.35-52.
Cauwe B., Van den Steen P.E., Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases //Crit. Rev. Biochem. Mol. Biol.- 2007.- Vol.42(3).- P.113–185.
Chubanov V., Waldegger S., Mederos Y. et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia //Proc. Natl. Acad. Sci. USA.- 2004.- Vol.101(9).- P.2894–2899.
Feng W., Benz F.W., Cai J. et al. Metallothionein disulfides are present in metallothionein–overexpressing transgenic mouse heart and increase under conditions of oxidative stress //J. Biol. Chem.- 2006.- Vol.281(2).- P.681–687.
Guo H., Lee J.D., Uzui H. et al. Effects of folic acid and magnesium on the production of homocysteine–induced extracellular matrix metalloproteinase–2 in cultured rat vascular smooth muscle cells //Circ. J.- 2006.- Vol.70(1).- P.141–146.
Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview //Front. Biosci.- 2006.- Vol.11.- P.1696–1701.
Pages N., Gogly B., Godeau G. et al. Structural alterations of the vascular wall in magnesium–deficient mice. A possible role of gelatinases A (MMP–2) and B (MMP–9) //Magnes Res.- 2003.- Vol.16(1).- P.43–48.
Shodikulova G.Z., Babamuradova Z.B., Toirov E.S. Clinical biochemical features in patients witch undifferentiated connective tissue dysplasia // European Science Review – Vena, 2016. – Volume 1, May. – Р.129-131.
Shodikulova G.Z., Babamuradova Z.B., Occurrence of clinical options of undifferentiated connective tissue dysplasia in uzbek population// International Journal of Psychosocial Rehabilitation. Volume 24-Issue 2.
Shodikulova G.Z., Babamuradova Z.B., Mirzaev O.V., Assessment of extracellular matrix condition in persons with undifferentiated connective tissue dysplasia// International Journal of Pharmaceutical Research. Volume 12-Issue
Shodikulova G.Z., Mirzaev O.V., Babamuradova Z.B. Prevalence of clinical options of undifferentiated connective tissue dysplasia in uzbek population// LXIV international correspondence scientific and practical conference “EUROPEAN RESEARCH: innovation in science, education and technology”/ - London, United Kingdom, 2020. - Р. 90-92
Tani C., Carli L., Vagnani S. et al. The diagnosis and classification of mixed connective tissue disease // J. Autoimmun. 2014. Vol. 48-49. Р. 46-49
